Neurocrine Biosciences Inc (NASDAQ: NBIX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT NEUROCRINE BIOSCIENCES INC

Neurocrine Biosciences Inc (NASDAQ: NBIX)
Listen to this Section


$177.11
N/A ( 0% ) 0.1K

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Market Data


Open $177.11
Previous Close $177.11
Volume 0.1K
Market Cap $17.81B
Day Range $178.25 - $178.25
52 Week Range $122.14 - $181.18
Shares Outstanding 100.55M
Change % 0%
Net Change N/A
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
IPO Year1996
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 11, 2025
4 Insider transactions 1 Jul 11, 2025
4 Insider transactions 1 Jul 07, 2025

Latest News